Effect of pH and Comedication on Gastrointestinal Absorption of Posaconazole (Q59285526)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21973269%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

title

Effect of pH and comedication on gastrointestinal absorption of posaconazole: monitoring of intraluminal and plasma drug concentrations (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21973269%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21973269%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Patrick F Augustijns

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21973269%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

author name string

Jeroen Walravens

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21973269%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Isabel Spriet

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21973269%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Jan Tack

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21973269%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Pieter Annaert

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21973269%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

publication date

1 November 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21973269%20AND%20SRC:MED&resulttype=core&format=json

Clinical Pharmacokinetics

14 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21973269%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

volume

50

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21973269%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21973269%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

page(s)

725-734

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21973269%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.2165/11592630-000000000-00000

14 February 2020

exact match

0 references

cites work

Antacids revisited: a review of their clinical pharmacology and recommended therapeutic use.

1 reference

12 December 2020

A comparative study of the in vitro susceptibilities of clinical and laboratory-selected resistant isolates of Aspergillus spp. to amphotericin B, itraconazole, voriconazole and posaconazole (SCH 56592).

1 reference

12 December 2020

Influence of an acidic beverage (Coca-Cola) on the absorption of itraconazole

1 reference

12 December 2020

The effect of gastric Acid on the absorption of posaconazole

1 reference

12 December 2020

Effect of food and gastric acidity on absorption of orally administered ketoconazole

1 reference

12 December 2020

Intraluminal drug and formulation behavior and integration in in vitro permeability estimation: a case study with amprenavir

1 reference

12 December 2020

Pharmacokinetics of posaconazole coadministered with antacid in fasting or nonfasting healthy men

1 reference

12 December 2020

Pharmacokinetics and absorption of posaconazole oral suspension under various gastric conditions in healthy volunteers

1 reference

12 December 2020

Effects of an acidic beverage (Coca-Cola) on absorption of ketoconazole

1 reference

12 December 2020

Short report: the absorption of fluconazole and itraconazole under conditions of low intragastric acidity

1 reference

12 December 2020

Effect of Carbonated Beverages and of an Antiemetic Containing Carbohydrate and Phosphoric Acid on Riboflavin Bioavailability and Salicylamide Biotransformation in Humans

1 reference

12 December 2020

1 reference

12 December 2020

Antifungal activities of posaconazole, ravuconazole, and voriconazole compared to those of itraconazole and amphotericin B against 239 clinical isolates of Aspergillus spp. and other filamentous fungi: report from SENTRY Antimicrobial Surveillance P

1 reference

12 December 2020

Progressive fusariosis: unpredictable posaconazole bioavailability, and feasibility of recombinant interferon-gamma plus granulocyte macrophage-colony stimulating factor for refractory disseminated infection

1 reference

12 December 2020

Pathophysiology of the upper gastrointestinal tract in the critically ill patient: rationale for the therapeutic benefits of acid suppression

1 reference

12 December 2020

What should be the first-choice strategy to maximize posaconazole exposure in daily clinical practice?

1 reference

12 December 2020

Effect of gastric and transpyloric tubes on gastric emptying and duodenogastric reflux.

1 reference

12 December 2020

Pharmacokinetics, safety, and tolerability of oral posaconazole administered in single and multiple doses in healthy adults

1 reference

12 December 2020

Antifungal serum concentration monitoring: an update

1 reference

12 December 2020

Gastric gas and fluid emptying assessed by magnetic resonance imaging

1 reference

12 December 2020

Reviews of anti-infective agents: posaconazole: a broad-spectrum triazole antifungal agent

1 reference

12 December 2020

Antifungal therapeutic drug monitoring: established and emerging indications

1 reference

12 December 2020

Effect of food on the relative bioavailability of two oral formulations of posaconazole in healthy adults

1 reference

12 December 2020

Effects of age, gender, and race/ethnicity on the pharmacokinetics of posaconazole in healthy volunteers

1 reference

12 December 2020

In vitro activities of posaconazole, fluconazole, itraconazole, voriconazole, and amphotericin B against a large collection of clinically important molds and yeasts

1 reference

12 December 2020

Disposition of posaconazole following single-dose oral administration in healthy subjects

1 reference

12 December 2020

Posaconazole: an extended-spectrum triazole antifungal agent

1 reference

12 December 2020

Oral bioavailability of posaconazole in fasted healthy subjects: comparison between three regimens and basis for clinical dosage recommendations

1 reference

12 December 2020

Effect of a cola beverage on the bioavailability of itraconazole in the presence of H2 blockers

1 reference

12 December 2020

Determination of intraluminal theophylline concentrations after oral intake of an immediate- and a slow-release dosage form.

1 reference

12 December 2020

Comparison of In vitro activities of the new triazole SCH56592 and the echinocandins MK-0991 (L-743,872) and LY303366 against opportunistic filamentous and dimorphic fungi and yeasts

1 reference

12 December 2020

In vitro activities of posaconazole (Sch 56592) compared with those of itraconazole and fluconazole against 3,685 clinical isolates of Candida spp. and Cryptococcus neoformans

1 reference

12 December 2020